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Summary
Objective: The objective of this study was to evaluate the feasibility of quantifying the Equilibrium Partitioning of an Ionic Contrast agent via
Microcomputed Tomography (EPIC-mCT) to nondestructively assess sulfated glycosaminoglycan (sGAG) content and distribution in rat artic-
ular cartilage ex vivo, and in doing so to establish a paradigm for extension of this technique to other small animal models.
Design: After determination of an appropriate incubation time for the anionic contrast agent, EPIC-mCT was used to examine age-related dif-
ferences in cartilage sGAG content between 4-, 8-, and 16-week old (n¼ 5 each) male Wistar rats and to evaluate sGAG depletion in the right
femora of each age group after 60 min of digestion with chondroitinase ABC. The EPIC-mCT measurements were validated by histological
safranin-O staining, and reproducibility was evaluated by triplicate scans of six femora.
Results: Cartilage attenuation gradually increased with cumulative digestion time and reached a plateau at approximately 60 min with a 16.0%
temporal increase (P< 0.01). Average femoral articular cartilage attenuation increased by 14.2% from 4- to 8-weeks of age (P< 0.01) and
further increased by 2.5% from 8 to 16 weeks (P< 0.05). After 60 min of digestion, femoral articular cartilage attenuations increased by
15e17% in each age group (P< 0.01). Correspondingly, sGAG optical density decreased with age and digestion, and showed a linear
correlation (r¼0.88, slope¼1.26, P< 0.01, n¼ 30) with EPIC-mCT cartilage attenuation. High reproducibility was indicated by a low
coefﬁcient of variation (1.5%) in cartilage attenuation.
Conclusions: EPIC-mCT imaging provides high spatial resolution and sensitivity to assess sGAG content and three-dimensional distribution in
rat femoral articular cartilage.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Proteoglycans (PGs), primarily aggrecan, comprise about
40% of articular cartilage by dry weight1 and carry a net
negative charge due to a high density of sulfated glycosami-
noglycans (sGAGs). PGs maintain hydration of the extracel-
lular matrix and contribute to mechanical properties in part
through electrochemical interactions2,3. The PG content
changes substantially during cartilage development4, de-
generation and repair5,6. PG loss is one of the earliest
symptoms of osteoarthritis and usually occurs before gross
morphological changes7. Studies involving animal tissues
indicate that even moderate decreases in PG concentration
can impair the load-bearing capacity of cartilage8e11, and
softened articular cartilage is susceptible to damage during
normal activity that contributes to cartilage erosion11. The
earliest degenerative changes may be reversible12e14, but*Address correspondence and reprint requests to: M. E.
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65current therapies are unable to regenerate cartilage once
collagen damage or gross tissue erosion begins. Detection
of early PG depletion (and potentially repletion) would thus
be valuable for the development and evaluation of novel re-
generative therapies.
Experimental small animal models are necessary and
complementary to clinical studies. A variety of small animal
models have been used for understanding pathogenesis
and evaluating the efﬁcacy of disease modifying drugs,
including surgical disruption models, intraarticular injection
of various agents, and spontaneous and genetically modiﬁed
models of osteoarthritis15,16. However, typical histological
and biochemical evaluation techniques are destructive,
time consuming, and incapable of describing the three-di-
mensional (3-D) spatial distribution of tissue constituents.
Current magnetic resonance imaging (MRI) techniques, in-
cluding delayed gadolinium-enhanced MRI of cartilage
(dGEMRIC), can produce 3-D, nondestructive measure-
ments of PG concentration in cartilage in vitro and in clinical
applications17e19. However, even high-powered research
MRI systems may not be adequate to detect local cartilage
changes in small animal joints. Therefore, there is a clear
need for imaging techniques that are capable of providing
66 L. Xie et al.: Rat cartilage composition via EPIC-mCT3-D, high resolution and nondestructive measurements of
cartilage composition in small animal joints (either in vivo
or ex vivo).
We previously introduced a novel imaging technique
measuring the Equilibrium Partitioning of an Ionic Contrast
agent via Microcomputed Tomography (EPIC-mCT), based
on the principle that a negatively charged, radioopaque con-
trast agent will be preferentially excluded from regions of
higher negative ﬁxed charge density associated with higher
PG concentration20. EPIC-mCT detected PG concentration
and distribution in cultured bovine cartilage explants,
providing high resolution, 3-D images of degeneration pat-
terns in vitro. The studies presented here aimed to establish
appropriate parameters for ex vivo imaging of the much
thinner cartilage of the rat distal femur, to evaluate the abil-
ity to track previously described differences in sGAG
concentration with age and in vitro chondroitinase ABC
digestion, and to validate the accuracy of EPIC-mCT
through qualitative and quantitative comparison to histolog-
ical analyses. In doing so, these studies demonstrate an
approach to determination of appropriate parameters and
validation that will facilitate application of EPIC-mCT to other
joints or animal models. These studies extend the applica-
tion of EPIC-mCT, establishing a nondestructive technique
to quantitatively evaluate the articular cartilage sGAG con-
tent and 3-D distribution for future hypothesis-driven studies
of joint degradation and repair in small animal models.MethodSPECIMEN PREPARATIONThe Georgia Institute of Technology Institutional Animal Care and Use
Committee approved experimental procedures. Male Wistar rats 4-, 8- and
16-weeks old (Charles River Laboratories, Sparks, NV) were sacriﬁced via
CO2 inhalation. The femora were harvested, dissected free of surrounding
tissues, and stored in phosphate buffered saline (PBS) with proteinase
inhibitors (PI, Cocktail I, CalBiochem, San Diego, CA) at 4C. For studies
involving enzymatic digestion, the distal femur was immersed in 1 ml
(0.1 U/ml) chondroitinase ABC (Sigma, St. Louis, MO) at 37C21.mCT SCANNING AND ANALYSISEach femur was consistently secured within a scanning tube such that the
diaphyseal axis was aligned with the vertical axis of the mCT scanning tube.
To reduce dehydration, the tube contained a small amount of PBS at the
bottom (not contacting the sample) and was sealed with Paraﬁlm. Samples
were scanned using a mCT 40 (Scanco Medical, Bassersdorf, Switzerland)
at 45 kVp, 177 mA and 200-ms integration time. Characterization studies
used a 12 mm scanning tube and a 12 mm voxel size, while subsequent stud-
ies used a 16 mm scanning tube and a 16 mm voxel size to accommodate
the largest samples. For EPIC-mCT, samples were immersed in a solution
of 40% Hexabrix 320 contrast agent (Mallinckrodt, Hazelwood, MO) and
60% PBS at 37C22 and gently patted dry before scanning.
A central region was deﬁned for each condyle by manually identifying the
scan slice ﬁrst intersecting cartilage and then selecting a ﬁxed number (see
below) of sequential slices from the cartilage surface. This region included
cartilage, subchondral bone, and some trabecular bone. Using Scanco Med-
ical software, a histogram of the X-ray attenuation values was produced,
revealing two peaks corresponding to contrast-enhanced articular cartilage
and calciﬁed bone. Lower and upper thresholds were manually assigned
to isolate the voxels within the cartilage peak, which also contained a few
(<3%) bone marrow voxels. The central cartilage attenuation for an individ-
ual condyle was deﬁned as the average attenuation for the thresholded
cartilage voxels of the central region, while the central cartilage attenuation
for an entire femur was similarly determined for pooled central cartilage vox-
els from both condyles.
To determine the average attenuation for the entire articular cartilage
layer, cartilage was segmented as previously described22. Femoral cross-
sections were transformed into sagittal sections via 3-D rotation of the gray-
scale image ﬁle, and contour lines were manually drawn on every 3e10
slices to eliminate marrow space. After semi-automatic contouring was
applied to the remaining slices, appropriate thresholds were identiﬁed from
an attenuation histogram to segment cartilage from bone. The 3-Dmorphology of the entire articular cartilage layer was then produced and
the average attenuation was determined.
For evaluation of depth-dependence, a sagittal slice through the center of
a condyle was isolated and the cartilage thickness at the highest point on the
surface was measured. A 400 mm wide region was subdivided into 10 equal
increments through the thickness, and the average attenuation of each incre-
ment was determined.HISTOLOGY AND ANALYSISFollowing scanning, femora were ﬁxed in 10% neutral buffered formalin
overnight and decalciﬁed in 2.5% formic acid (pH 4.2) for 10 days. Dehy-
drated samples were embedded in glycol methacrylate according to the
manual of the JB-4 embedding kit (Polysciences, Warrington, PA). For com-
parison with EPIC-mCT images, sagittal sections were cut at 8 mm thickness
and one section through the center of each condyle was examined. Sections
were stained for sGAGs with a 0.5% safranin-O solution and a 0.2% aque-
ous solution of fast green as a counterstain. Digital images of each section
were captured at 0.5 mm resolution under controlled ambient light. The im-
ages were exported to Matlab (MathWorks, Natick, MA), red, green and
blue image components were isolated, and a red content parameter (Rc,)
representing the sGAG optical density (sGAG-OD) was determined by non-
linear weighting of the fractional intensity of the red component23. The carti-
lage was manually outlined and the femur’s sGAG-OD was determined by
averaging the average Rc values from the two condyles. Depth-dependent
sGAG-OD was examined by dividing a 400 mm wide central of cartilage
into 10 equal increments and determining the average Rc for each increment.CHARACTERIZATION STUDIESAs the time required for equilibration varies depending on the contrast
agent, tissue composition, and tissue thickness, the appropriate equilibration
time for rat femoral cartilage was ﬁrst determined. Femora (n¼ 3) from 8-
week old rats were pre-scanned before exposure to the contrast agent.
Each sample was then immersed in contrast solution for 5 min and rescanned.
This process was repeated for cumulative immersion times of 0, 5, 10, 15, 30,
and 60 min. As handling and scanning required approximately 30 min, it
should be noted that intermittent exposure may have produced somewhat dif-
ferent kinetics than continuous exposure. Central cartilage attenuation was de-
termined for a region extending 372 mm (31 slices) from the cartilage surface.
To determine an appropriate digestion time, femora (n¼ 4) from 8-week
old rats were immersed in contrast solution for 30 min (based on results of
the time-course study) and scanned. Samples were incubated in PBS for
30 min to desorb the contrast agent, digested with chondroitinase ABC for
10 min, then re-immersed in contrast solution and rescanned. This process
was repeated for cumulative digestion times of 10, 20, 30, 40, 60, 80, and
120 min to simulate progressive degradation. Cartilage attenuation for
each femur was determined as described above.
To evaluate the reproducibility of EPIC-mCT attenuation measurements,
femora from 4-week old (n¼ 4) and 8-week old (n¼ 2) rats were immersed
in contrast solution for 30 min and scanned. After incubation for 1 h in PBS
(sufﬁcient to desorb the contrast agent), the femora were re-immersed in
contrast solution and re-scanned. After overnight storage in PBS at 4C,
a third immersion and scan was performed. The attenuation averaged over
the entire cartilage layer was determined for each scan, and the coefﬁcient
of variation (100 times the standard deviation (SD) divided by the mean)
was calculated for each sample. The root mean square coefﬁcient of varia-
tion (RMS-CV) and root mean square standard deviation (RMS-SD)24 were
calculated and averaged for the six samples.sGAG VARIATION WITH AGE AND DIGESTIONBoth femora were harvested from 4-week, 8-week, and 16-week old
(n¼ 5 each) rats, incubated in contrast solution for 30 min and scanned.
The average attenuation of the entire cartilage layer and the central cartilage
attenuations for both condyles were determined for each femur. Reﬂecting
the decrease in cartilage thickness with age, the central regions extended
from the cartilage surface to depths of 496 mm (31 slices) in 4-week old
rats, 336 mm (21 slices) in 8-week old rats and 256 mm (16 slices) in 16-
week old rats. After scanning, right femora were incubated in PBS for
30 min to desorb the contrast agent, digested with chondroitinase ABC for
60 min, re-incubated with the contrast agent for 30 min and rescanned.
Following scanning, undigested left and digested right femora were ﬁxed,
embedded and stained, and analyzed to determine the sGAG-OD.STATISTICAL ANALYSISCartilage attenuations in the characterization studies were evaluated via
one-way repeated measures analysis of variance (ANOVA). General linear
models (factors in parentheses) were used to evaluate effects of age on
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Fig. 1. Optimization of incubation time for EPIC-mCT in the rat distal
femur. Time course of central cartilage attenuation (n ¼ 3,
meanSD). The stabilization of central cartilage attenuation indi-
cated that 30 min of incubation was sufﬁcient for Hexabrix to reach
equilibration. #P< 0.01 vs 5 min, *P< 0.05 vs 10 min.
67Osteoarthritis and Cartilage Vol. 18, No. 1cartilage attenuation (age, animal, limb) or sGAG-OD in undigested femurs
(age), effects of digestion on cartilage attenuation (age, animal, digestion)
or sGAG-OD (age, animal, digestion), with age as a between-groups factor
and animal nested within age. Regional cartilage attenuation was evaluated
with a two factor mixed general linear model (age, condyle) with condyle as
a repeated measure. Tukey’s test was used for post-hoc analyses. The rela-
tionship between cartilage attenuation and sGAG-OD was examined via lin-
ear regression analysis. Statistical signiﬁcance was set at P< 0.05 (SPSS
11, SPSS Inc., Chicago, IL or Minitab 15, Minitab Inc., State College, PA).
All data are presented as meanSD.ResultsCHARACTERIZATION STUDIESThe average attenuation of femoral articular cartilage with-
out incubation (65 2, expressed in threshold units) was
close to that of PBS (58), and increased over 60 min to an
attenuation of 193 7. Cartilage attenuation achieved 69%
of the ﬁnal increase by 5 min (Fig. 1), 85% by 10 min
(P< 0.01 vs 5 min), 92% by 15 min (P< 0.01 vs 5-min),
and 99% by 30 min (P< 0.05 vs 10 min). There were noFig. 2. Sagittal sections of baseline mCT scan (Left); EPIC-mCT scan (Mi
femur from a 4-week old rat. The baseline mCT scan without contrast a
soft tissues were presented in blue (Left). EPIC-mCT clearly distinguishe
cartilage had a lower contrast agent content and thus X-ray attenuation
red). Safranin-O staining of the same femur showed cartilage insigniﬁcant differences in attenuation among incubation times
of 15, 30 and 60 min. Consequently, incubation for 30 min
was used in subsequent studies. Using this protocol, the
RMS-CV for cartilage attenuation determined by triplicate
scanning of six samples was 1.5%, and the RMS-SD was
2.1%.
Color images representing the range of X-ray attenuation
values were generated using Scanco Medical image pro-
cessing software. As expected, the baseline mCT scan
failed to distinguish cartilage from other soft tissues, as all
of the soft tissues exhibited similar attenuations (65, blue,
Fig. 2 left). However, EPIC-mCT clearly identiﬁed cartilage
from bone and adjacent non-cartilaginous soft tissues
such as ligaments. Due to the higher negative ﬁxed charge
density, articular cartilage had lower contrast agent content
and thus lower X-ray attenuation (140, green and yellow,
Fig. 2 middle) compared to other soft tissues (240, dim
red, Fig. 2 middle). Safranin-O staining of the same femur
showed cartilage morphology consistent with the EPIC-
mCT images, with cartilage appearing dark red while other
soft tissues appeared green (Fig. 2 right).
Color-coded images were generated to visualize varia-
tions in attenuation during digestion [Fig. 3(A)]. As expected
for decreasing sGAG content, the average central cartilage
attenuation increased from 187 10 before digestion to
a plateau (217 7) at approximately 60 min of digestion
[Fig. 3(B)]. The 16.0% increase in average cartilage attenu-
ation (P< 0.05 vs original measurement) was maintained
from 60e120 min of digestion. Consequently, digestion for
60 min was used in subsequent studies.sGAG VARIATION WITH AGE AND DIGESTIONRepresentative sagittal EPIC-mCT images [Fig. 4(AeC)]
demonstrate that cartilage attenuation increased with age,
while representative safranin-O stained images
[Fig. 4(GeI)] illustrate that sGAG-OD decreased with age.
Consistent with the visual assessment, attenuation ofddle); and histological staining with safranin-O (Right) of the same
gent failed to distinguish cartilage from other soft tissues and all
d cartilage from bone and adjacent soft tissues (Middle). Articular
(140, green and yellow) compared to other soft tissues (240, dim
dark red color and other soft tissues in green color (Right).
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Fig. 3. Time course of central cartilage attenuation during chondroitinase ABC digestion. (A) Representative EPIC-mCT images of femoral ar-
ticular cartilage after digestion with chondroitinase ABC for 0, 10, 30 and 60 min cumulative exposure times. Average attenuation expressed in
threshold units is shown in parentheses. (B) The central cartilage attenuation of femoral articular cartilage during intermittent chondroitinase
ABC digestion for cumulative exposure times up to 120 min (n¼ 4, mean SD). #P< 0.05 vs undigested cartilage (time¼ 0).
68 L. Xie et al.: Rat cartilage composition via EPIC-mCTthe distal femoral cartilage layer increased by 14.2% from 4-
to 8-weeks of age [157.6 4.8 vs 138.1 1.8, n¼ 10,
P< 0.0001, Fig. 5(A)], and further increased by 2.5% from
8- to 16-weeks of age (161.5 2.3 vs 157.6 4.8, n¼ 10,
P¼ 0.002). The means of relative differences25 (absolute
difference between left and right femora divided by the
mean of both femora) for central cartilage attenuation for
a given age group ranged from 0.9% to 2.0%, without signif-
icant differences between right and left limbs [Fig. 5(A)].
sGAG-OD in the left femoral articular cartilage decreased
by 13.9% from 4- to 8-weeks of age [65.4 3.2 vs
76.0 2.9, n¼ 5, P< 0.001, Fig. 5(B)], but did not signiﬁ-
cantly decrease from 8- to 16-weeks of age (60.2 4.0 vs
65.4 3.2, n¼ 5, P¼ 0.08).
EPIC-mCT revealed progressive differences with matura-
tion between medial and lateral condyle attenuations. The
central cartilage attenuation of medial and lateral condyles
did not signiﬁcantly differ in 4-week old rats (141.5 3.6
vs 140.1 4.3, P¼ 0.41, n¼ 10). However, the attenua-
tions in medial condyles were 8.5% (195.7 13.6 vs
180.5 11.6, P< 0.01, n¼ 10) and 9.9% (211.4 12.6 vs
192.3 12.3, P< 0.01, n¼ 10) higher in 8-week and 16-
week old rats, respectively, indicating a lower sGAG content
in the medial condyles at these ages.
Representative sagittal EPIC-mCT images [Fig. 4(DeF)]
and safranin-O stained images [Fig. 4(JeL)] demonstrate
that chondroitinase ABC digestion increased cartilage atten-
uation anddecreased sGAG-ODacross ages. After 60 min of
digestion, the cartilage attenuation in the right femora in-
creased by 17% to 160.8 10.4 [n¼ 5, P< 0.01, Fig. 5(A)]
compared to normal cartilage in left or right femora in the
4-week age group, by 16% to 182.8 6.6 (n¼ 5, P< 0.01)
in the 8-week age group, and by 15% to 185.2 4.2 (n¼ 5,
P< 0.01) in the16-weekagegroup.Compared tonormal car-
tilage in the left femora, sGAG-OD of digested articular carti-
lage in the right femora was lower by 18.9% at 61.6 3.4
[n¼ 5, P< 0.01, Fig. 5(B)] in the 4-week age group, by30.6% at 45.4 3.4 (n¼ 5, P< 0.01) in the 8-week age
group, and by 29.6% at 42.4 3.0 (n¼ 5, P< 0.01) in the
16-week age group. There was a strong, linear relationship
[r¼0.88, slope¼1.26, P< 0.01, n¼ 30, Fig. 5(C)] be-
tween cartilage attenuation and sGAG-OD for cartilage
pooled across age and digestion states.
In 4-week old rats, the attenuation [Fig. 6(A)] decreased
from the superﬁcial zone (177 7) to the deep zone
(101 6) and reached the lowest value in the bottom of
middle zone (97 6), corresponding to the highest sGAG
level. As expected, the contrast agent achieved higher
concentrations in digested cartilage, with increased X-ray
attenuation in the superﬁcial (211 9), middle (171 7)
and deep zones (163 8). Histological sections revealed
consistent sGAG distributions in normal and digested carti-
lage [Fig. 6(B)]. In normal cartilage, sGAG-OD increased
from the superﬁcial zone (41 5) to the deep zone
(83 4). After digestion, the cartilage exhibited decreases
in sGAG-OD progressing from the superﬁcial zone
(26 5) to the deep zone (73 5). The poorly stained
regions (superﬁcial zone) were consistent with the locations
of increased attenuation in the EPIC-mCT images (Fig. 4).Discussion
Nondestructive techniques capable of assessing carti-
lage composition and distribution in rodents would greatly
beneﬁt the development of effective osteoarthritis treat-
ments and cartilage repair strategies. These studies dem-
onstrated that EPIC-mCT provides high spatial resolution
and sensitivity to assess changes in sGAG concentration
within rat femoral articular cartilage, expanding the applica-
tion of mCT from mineralized hard tissues to soft tissues.
EPIC-mCT was able to clearly distinguish articular cartilage
from bone and adjacent non-cartilaginous soft tissues (al-
though the distinction from other soft tissues may diminish
Fig. 4. EPIC-mCT images and corresponding histological sections show similar patterns of changes in sGAG content with age and digestion.
(AeF): Representative sagittal sections of undigested (AeC) and digested (DeF) distal femora from EPIC-mCT imaging for male Wistar rats at
4-, 8- and 16-weeks of age. The insets display magniﬁed images of the central regions of the condyles. Normal cartilage, characterized by high
sGAG content and low attenuation, appeared in green, while the digested cartilage, characterized by low sGAG content and high attenuation,
appeared in yellow-red. (GeL): Representative safranin-O stained sagittal sections of undigested (GeI) and digested (JeL) distal femora from
male Wistar rats at 4-, 8- and 16-weeks of age. Normal cartilage exhibited a dense distribution of sGAGs (red). In contrast, digested cartilage
exhibited visible decreases in sGAG staining progressing from the superﬁcial zone to the deep zone.
69Osteoarthritis and Cartilage Vol. 18, No. 1with degeneration), and allowed visualization of the spatial
distribution of sGAGs in the thin articular cartilage of the
rat. EPIC-mCT had high precision in repeated measure-
ments and demonstrated high sensitivity for detecting differ-
ences in sGAG content of rat articular cartilage with
maturation and in vitro enzymatic digestion. Importantly,
the inverse relationship between EPIC-mCT attenuation
and sGAG content was validated by histological analysis,demonstrating a strong linear relationship between sGAG-
OD and cartilage attenuation.
Current quantitative analyses for sGAG concentration
include histological staining and biochemical assays using
cationic dyes, dGEMRIC26, sodium MRI27, and the EPIC-
mCT technique employed in this study, all of which
measure the negative electrical charge of the extracellular
matrix as an indication of sGAG concentration. EPIC-mCT,
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Fig. 5. Quantitative analysis of changes in cartilage attenuation and sGAG-OD with age and digestion. (A) Average EPIC-mCT attenuation of
the cartilage layer for undigested left femora, undigested right femora, and digested right femora for each age group (n¼ 5, meanSD).
*P< 0.01 vs 4-week old rats, #P< 0.05 vs 8-week old rats,6P< 0.01 vs undigested (left or right) femora. (B) Average sGAG-OD for central
condyle region of undigested left femora and digested right femora for each age group (n¼ 5, meanSD). *P< 0.01 vs 4-week old rats,
6P< 0.01 vs undigested left femora. (C) Linear regression of cartilage attenuation vs sGAG-OD for femora pooled across ages and digestion
states (r¼0.88, slope¼1.26, P< 0.01, n¼ 30).
70 L. Xie et al.: Rat cartilage composition via EPIC-mCTwith inherently higher spatial resolution than dGEMRIC,
was shown in this study to provide the 3-D spatial distribu-
tion of X-ray attenuation and therefore sGAG concentra-
tion throughout the articular cartilage layer in rats. The
mechanical properties of articular cartilage are site-de-
pendent28, and EPIC-mCT images may be helpful in
exploring structureefunction relationships between local
mechanical properties and sGAG concentration10,29,30.
Additionally, measurement of sGAG concentration may
be a useful surrogate for tissue mechanical properties in
small animals where it is difﬁcult to directly assess mate-
rial properties.
Depth-dependent patterns of cartilage attenuation could
arise from incomplete diffusion of the contrast agent. In thatCont
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Fig. 6. sGAG distribution through the thickness of normal and digested c
(A) Average EPIC-mCT attenuation vs depth determined from a 2D image
(B) Average sGAG-OD vs depth for corresponding scase the cartilage attenuation would be lowest in the deep
zone, but the lowest attenuationwas found towards thebottom
ofmiddle zone (Fig. 6)where the sGAGcontent is highest31,32.
Observations of higher cartilage attenuation in digested carti-
lage than in normal cartilage further indicate that the matrix
charge enabled the contrast agent to distribute in accordance
with sGAG concentration33. A previous MRI study demon-
strated a non-uniform distribution of an ionic contrast agent
(gadolinium) in cartilage but a uniform distribution of a similarly
sized neutral contrast agent (gadoteridol) that was indepen-
dent of regional sGAG concentration33,34. These ﬁndings sug-
gest that the non-uniform distributions were governed by the
electrical chargeof contrast agents andnot by the effect ofmo-
lecular ﬁltering within the cartilage matrix35.rol Digested
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artilage from the medial condyles of femora from 4-week old rats.
slice through the center of the medial condyle (n¼ 5, mean SD).
afranin-O stained images (n¼ 5, meanSD).
71Osteoarthritis and Cartilage Vol. 18, No. 1The staining intensity of safranin-O, a cationic dye that
binds to sGAG, has been used to semi-quantitatively eval-
uate sGAG concentration with high accuracy and reproduc-
ibility23,36. In this study, the close correspondence between
EPIC-mCT images and safranin-O staining and the strong,
negative relationship between EPIC-mCT attenuation and
sGAG-OD suggest that EPIC-mCT could be a sensitive
and speciﬁc measure of local sGAG content, with potential
for in situ estimation of relative sGAG concentrations in rat
articular cartilage.
Precision is a critical factor for animal studies, inﬂuencing
both the number of experimental animals needed and the re-
quired duration of the study. Measurements with low
precision may fail to detect the slow evolution of arthritis pro-
gression24,37. The small coefﬁcients of variation and SDs
demonstrated ahigh level of precision for theEPIC-mCT tech-
nique. Based on our results, EPIC-mCT is expected to have
80%power and 95%conﬁdence to detect a 1.3%cartilage at-
tenuation difference with a sample size of 10, while the
changes of cartilage attenuation in this study were over
2.5% during cartilage development and over 15% during di-
gestion. The high precision was further indirectly validated
by the smallmean relative difference (<2%) in cartilageatten-
uation between left and right femora.
Cartilage attenuation from EPIC-mCT was used to semi-
quantitatively evaluate cartilage maturation and degradation
in this study, and the results demonstrated that EPIC-mCT
hashigh sensitivity to assess the changeof sGAGcontent as-
sociated with age and digestion. EPIC-mCT images showed
that cartilage attenuation increased with the age of rats, indi-
cating that sGAG concentration gradually decreased during
cartilage maturation. This decrease was validated by safra-
nin-O staining and is consistent with previous biochemical
studies4. In theex vivodegradation study, bothEPIC-mCT im-
aging and histologymethods indicated that sGAGconcentra-
tion signiﬁcantly decreased for digested cartilage. Based on
a baseline characterization of normal cartilage attenuation
across an age range, EPIC-mCT may have the capability to
nondestructively determine the degree of degradation within
the cartilage in rat models of arthritis, facilitating the evalua-
tion of disease progression and the efﬁcacy of cartilage de-
fect therapies. For example, based on results presented
here, a cartilage region in an 8-week old rat could be tenta-
tively classiﬁed as degraded if the local attenuation exceeded
the upper 95% conﬁdence limit of 167.2.
In addition to the evaluation of the average attenuation
(sGAG concentration) of the entire femoral articular carti-
lage layer, EPIC-mCT demonstrated the capability to assess
sGAG content in focal regions. The results indicating lower
sGAG contents in the medial condyles are consistent with
previous studies38e40, possibly reﬂecting lower stiffness in
medial condyle41. It is also feasible to assess and compare
other focal regions, such as condyles vs groove and weight
bearing vs non-weight bearing regions42. Considering the
high resolution (up to submicrometer)43, EPIC-mCT also
has potential to analyze the sGAG concentration in mouse
cartilage, which has an approximate articular cartilage thick-
ness of 100 mm or less44,45.
Chondroitinase ABC speciﬁcally degrades chondroitin
sulfate and dermatan sulfate chains and provides a repro-
ducible experimental model of decreased sGAG con-
tent21,46. In the enzymatic digestion study, sGAG
depletion was primarily observed in the superﬁcial zone
because the enzyme was large enough (150 kD) to restrict
early access to the deep zone47. sGAG depletion preceding
apparent loss of tissue was consistent with early osteoar-
thritic symptoms10,32. These data suggest that EPIC-mCThas the capability to nondestructively assess local sGAG
depletion that may occur in early stages of focal defect
formation in experimental osteoarthritis.
Although sGAG concentration was indirectly validated by
histological analysis, questions still remain regarding the
direct correspondence of cartilage attenuation to absolute
sGAG concentration. The limited thickness and volume of
rat articular cartilagemakes it difﬁcult or impossible to extract
enough samples to calibrate sGAG concentration as a func-
tion of cartilage attenuation. According to electrochemical
equilibrium (Donnan) theory, cartilage attenuation for a given
level of tissue hydration is determined by the sGAG concen-
tration with a given incubation condition. This theoretical
speculation was validated by a previous biochemical assay
in calf cartilage explants which demonstrated a negative lin-
ear relationship between sGAG concentration and cartilage
attenuation20. However, the calibration curve may vary with
factors such as collagen content and orientation, ﬂuid volume
fraction, and status of degradation. Once these factors are
understood, development of an appropriate calibration curve
will allowEPIC-mCT toprovide a 3-Ddistributionmapofabso-
lute sGAG concentration in the rat. It is important to note that
the quantitative assessment of sGAG content relies on an
equilibrium contrast agent distribution that currently can
only be imposed ex vivo. The potential for in vivo application
is supported by a recent report that contrast-enhanced in vivo
mCT arthrography was able to detect cartilage degeneration
in rat patellae in an experimental osteoarthritis model48.
While issues such as contrast agent clearance from the joint
space make in vivo quantiﬁcation of sGAG content challeng-
ing, combined application of complementary in vivo and ex
vivo implementations may be provide the best results.
In summary, the present study established a semi-quan-
titative, high-resolution, 3-D imaging technique capable
of nondestructively assessing sGAG concentration and
distribution (as well as cartilage morphology22) for end-
stage analysis in small animals. EPIC-mCT will dramatically
beneﬁt studies of cartilage maturation and aging, degrada-
tion and regeneration18, tissue engineering constructs,
pathogenesis of osteoarthritis, and the efﬁcacy of pharma-
cologic therapies in small animal models.Conﬂict of interest
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